Quantcast

Latest abdominal aortic aneurysm Stories

2010-02-24 08:00:00

IRVINE, Calif., Feb. 24 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the ROTH 22nd Annual OC Growth Stock Conference at The Ritz-Carlton Hotel in Laguna Niguel, CA. Event: ROTH 22nd Annual OC Growth Stock Conference Date: Monday, March 15, 2010 Time: 9:30 a.m. PT An audio Web...

2010-02-11 10:30:00

IRVINE, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its fourth quarter and full year 2009 financial results, which will take place on Thursday, February 18, 2010 after the close of the market. Endologix will hold a conference call on Thursday, February 18, 2010 at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The dial-in numbers are (877)...

2010-01-27 16:49:35

New research findings from a team at the Providence Heart + Lung Institute at St. Paul's Hospital and the University of British Columbia (UBC) may lead to new treatment options for abdominal aortic aneurysms (AAA) "“ a potentially fatal disease that currently has no pharmacological treatments. An aortic aneurysm is a bulging of the aorta, the largest blood vessel in the body. If the aneurysm ruptures, it causes rapid blood loss and a high risk of death. About 75 per cent of all aortic...

2010-01-05 09:54:00

CHICAGO, Jan. 5 /PRNewswire/ -- A new study in the January issue of the Journal of Vascular Surgery(®), published by the Society for Vascular Surgery®, reveals robust epidemiological evidence that hereditary factors contribute to aneurysm formation in twins. Researchers in Sweden reviewed the data of 172,890 twins born in that country since 1886 and found 265 twins who had developed abdominal aortic aneurysms (AAAs). These individuals ranged from 48 to...

2009-12-10 16:42:00

IRVINE, Calif., Dec. 10 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that Dan Lemaitre, former President and CEO of CoreValve, has joined the Endologix Board of Directors effective December 11, 2009. Endologix now has four independent directors and three non-independent directors. Franklin D. Brown, Chairman of the Board, said, "We are pleased to welcome Dan Lemaitre to the Endologix Board of...

2009-11-18 12:57:00

IRVINE, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has received Investigational Device Exemption (IDE) conditional approval from the United States Food and Drug Administration ("FDA") to begin a prospective, multicenter, randomized clinical trial for a bilateral percutaneous approach to endovascular abdominal aortic aneurysm repair (EVAR) utilizing the Company's...

2009-11-03 15:05:00

IRVINE, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at three upcoming investor conferences. The first presentation will be at the Canaccord Adams 3rd Annual Cardiovascular Conference at the Nikko Hotel in San Francisco, CA. Event: Canaccord Adams 3rd Annual Cardiovascular Conference...

2009-10-16 08:00:00

IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its third quarter 2009 financial results, which will take place on Tuesday, October 27, 2009 after the close of the market. Endologix will hold a conference call on Tuesday, October 27, 2009 at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The dial-in numbers are (877) 407-0789 for...

2009-10-13 15:23:00

IRVINE, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has conducted further evaluation of the patent infringement lawsuit filed against the company last week by Cook Medical, and of the patents asserted in the lawsuit. Based upon this evaluation, Endologix believes that the alleged infringement is without merit and the company intends to vigorously defend its position....

2009-10-13 16:07:23

Patients who received the less-invasive endovascular repair of an abdominal aortic aneurysm had a lower risk of death in the first 30 days after the procedure compared to patients who an open repair, but both procedures had similar rates of death after two years, according to a study in the October 14 issue of JAMA, a theme issue on surgical care. Frank A. Lederle, M.D., of the Veterans Affairs Medical Center, Minneapolis, presented the findings of the study at a JAMA media briefing in...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related